Another stroke therapy utilizing the potential of IL-6 could be modulation of the trans signaling pathway, enhancing trans signaling at an early stage or suppressing it at a later stage, to avoid a neuroinflammatory response [34,53,54]. The gene discussed is IL6; the disease is stroke disorder.